RESEARCHER PROFILE

Peter Chedraui

← Back to Universidad Espíritu Santo

P

Universidad Espíritu Santo

Menopause: Health Impacts and TreatmentsSexual function and dysfunction studiesOvarian function and disordersAdrenal Hormones and DisordersDiabetes, Cardiovascular Risks, and Lipoproteins

Peter Chedraui works in Menopause: Health Impacts and Treatments, Sexual function and dysfunction studies, Ovarian function and disorders, Adrenal Hormones and Disorders, Diabetes, Cardiovascular Risks, and Lipoproteins. Recorded institutional associations include Universidade de São Paulo, Universidad Espíritu Santo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.

20Publications
25Citations
3H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The Impact of the Menopausal Transition on Body Composition and Abdominal Fat Redistribution

    2026 · 10 citations
  2. Gut microbiota and metabolic syndrome in postmenopausal women: a narrative review of mechanisms and dietary recommendations

    2026 · 4 citations
  3. Do menopausal symptoms signal early biological aging? Mitochondrial, endocrine and clinical insights

    2026 · 3 citations
  4. Severity of menopausal symptoms is associated with lower work-related quality of life and job satisfaction in midlife Latin American women: REDLINC XIII

    2026 · 2 citations
  5. Melatonin Enhances Glutathione Peroxidase Activity and Improves Antioxidant Defense in Cryopreserved Ovarian Transplants: A Rat Model Study

    2026 · 2 citations
  6. Physical activity as an alternative or adjunct to menopausal hormone therapy for symptom management in women with primary ovarian insufficiency

    2026 · 1 citations
  7. Frozen-Thawed ovarian autografts treated with scaffold-based melatonin delivery in rats

    2026 · 1 citations
  8. Endometriosis beyond menopause: a call for greater clinical awareness

    2026 · 1 citations
  9. Uric Acid–to–HDL cholesterol ratio and probable MASLD across adiposity strata in postmenopausal women

    2026 · 1 citations
  10. Hot flashes: a potential marker of deterioration of health-related quality of life

    2026 · 0 citations
  11. Impaired quality of life among middle aged women: Amulticentre Latin American study

    2008 · 0 citations
  12. Migraine Throughout Women’s Reproductive Life: Unravelling the Cardiovascular and Metabolic Implications

    2026 · 0 citations
  13. Drawbacks in dopaminergic neurotransmission: compromising sexual performance

    2026 · 0 citations
  14. From ‘polycystic ovary syndrome’ to ‘polyendocrine metabolic ovarian syndrome’: why terminology matters

    2026 · 0 citations
  15. FDA safety concerns and menopausal-like symptoms in postmenopausal statin users

    2026 · 0 citations
  16. Hormonal and metabolic effects of the administration of oral low-dose 17-β-estradiol (0.2 mg) in patients with functional hypothalamic amenorrhea: a retrospective pilot study

    2026 · 0 citations
  17. Perimenopausal symptom burden: implications for health, work and earlier clinical management

    2026 · 0 citations
  18. Combined treatment with L-Glutathione, D-Chiro-Inositol, Myo-inositol and N-Acetylcysteine reduces insulin resistance in overweight/obese patients with polycystic ovary syndrome

    2026 · 0 citations
  19. Dydrogesterone and inflammatory marker regulation: a systematic review and quantitative meta-analysis

    2026 · 0 citations
  20. Association of statin use with severe urogenital symptoms and lower sexual function in postmenopausal women: a cross-sectional study

    2026 · 0 citations

← Return to the university profile